The osteogenesis of bacterial cellulose scaffold loaded with bone morphogenetic protein-2

Biomaterials

Volumn 33, Issue 28, 2012, Pages 6644-6649

  Shi, Qin ^a,b   Li, Yang ^a,b   Sun, Jie ^c   Zhang, Hua ^b   Chen, Lei ^c   Chen, Bing ^c   Yang, Huilin ^b   Wang, Zhaoxu ^a  

^a NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

Author keywords

Bacterial cellulose scaffold; Bone morphogenetic protein 2; Nanofibrous; Osteogenesis

Indexed keywords

ACETOBACTER XYLINUM; ACTIVITY ASSAYS; ALKALINE PHOSPHATASE ACTIVITY; BACTERIAL CELLULOSE; BONE FORMATION; BONE MORPHOGENETIC PROTEIN-2; BONE TISSUE ENGINEERING; C2C12 CELLS; CALCIUM CONCENTRATION; COLLAGENOUS FIBERS; CYTOKINES; IN-VITRO; IN-VIVO; LOCALIZED DELIVERY; NANO-FIBROUS; OSTEOGENESIS; OSTEOGENIC ACTIVITY; OSTEOGENIC POTENTIAL; PHYSICOCHEMICAL PROPERTY;

BIOCOMPATIBILITY; BIOLOGICAL MATERIALS; BONE; CELL CULTURE; CELLULOSE; NANOFIBERS; OSTEOBLASTS; PHOSPHATASES;

SCAFFOLDS (BIOLOGY);

ALKALINE PHOSPHATASE; BACTERIAL CELLULOSE; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; CELLULOSE; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BONE DEVELOPMENT; CALCIUM BONE LEVEL; CELL DIFFERENTIATION; CHEMICAL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ECTOPIC TISSUE; ENZYME ACTIVITY; FIBROBLAST; GLUCONACETOBACTER XYLINUS; IMPLANTATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MATERIAL COATING; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; RAT; TISSUE ENGINEERING;

ANIMALS; BONE AND BONES; BONE MORPHOGENETIC PROTEIN 2; CELL LINE; CELLULOSE; GLUCONACETOBACTER XYLINUS; MALE; MICE; MICROSCOPY, ELECTRON, SCANNING; NANOFIBERS; OSTEOBLASTS; OSTEOGENESIS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

BACTERIA (MICROORGANISMS); GLUCONACETOBACTER XYLINUS;

EID: 84864004232     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.05.071     Document Type: Article

References (40)

1. Ewers R., Goriwoda W., Schopper C., Moser D., Spassova E. Histologic findings at augmented bone areas supplied with two different bone substitute materials combined with sinus floor lifting. Report of one case. Clin Oral Implants Res 2004, 15:96-100.
2. Brems J.J. Role of bone graft substitutes for glenoid bone defects. J Shoulder Elbow Surg 2007, 16:S282-S285.
3. Hardouin P., Anselme K., Flautre B., Bianchi F., Bascoulenguet G., Bouxin B. Tissue engineering and skeletal diseases. Jt Bone Spine 2000, 67:419-424.
4. Helenius G., Backdahl H., Bodin A., Nannmark U., Gatenholm P., Risberg B. In vivo biocompatibility of bacterial cellulose. J Biomed Mater Res A 2006, 76:431-438.
5. Backdahl H., Helenius G., Bodin A., Nannmark U., Johansson B.R., Risberg B., et al. Mechanical properties of bacterial cellulose and interactions with smooth muscle cells. Biomaterials 2006, 27:2141-2149.
6. Andrade F.K., Costa R., Domingues L., Soares R., Gama M. Improving bacterial cellulose for blood vessel replacement: functionalization with a chimeric protein containing a cellulose-binding module and an adhesion peptide. Acta Biomater 2010, 6:4034-4041.
7. Hong L., Wang Y., Jia S., Huang Y., Gao C., Wan Y. Hydroxyapatite/bacterial cellulose composites synthesized via a biomimetic route. Mater Letters 2006, 60:1710-1713.
8. Bostrom M.P., Asnis P. Transforming growth factor beta in fracture repair. Clin Orthop Relat Res 1998, S124-S131.
9. Chen D., Zhao M., Mundy G.R. Bone morphogenetic proteins. Growth Factor 2004, 22:233-241.
10. Chen B., Lin H., Wang J., Zhao Y., Wang B., Zhao W., et al. Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagen-targeting bone morphogenetic protein-2. Biomaterials 2007, 28:1027-1035.
11. Yoon B.S., Lyons K.M. Multiple functions of BMPs in chondrogenesis. J Cell Biochem 2004, 93:93-103.
12. Chu T.M., Warden S.J., Turner C.H., Stewart R.L. Segmental bone regeneration using a load-bearing biodegradable carrier of bone morphogenetic protein-2. Biomaterials 2007, 28:459-467.
13. Ruhe P.Q., Boerman O.C., Russel F.G., Mikos A.G., Spauwen P.H., Jansen J.A. In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin. J Mater Sci Mater Med 2006, 17:919-927.
14. Ha J.H., Shah N., Ul-Islam M., Khan T., Park J.K. Bacterial cellulose production from a single sugar [alpha]-linked glucuronic acid-based oligosaccharide. Process Biochem 2011, 46:1717-1723.
15. Bae S.O., Shoda M. Production of bacterial cellulose by Acetobacter xylinum BPR2001 using molasses medium in a jar fermentor. Appl Microbiol Biotechnol 2005, 67:45-51.
16. Hollinger J.O., Schmitt J.M., Buck D.C., Shannon R., Joh S.P., Zegzula H.D., et al. Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration. J Biomed Mater Res 1998, 43:356-364.
17. Aro H.T., Govender S., Patel A.D., Hernigou P., Perera de Gregorio A., Popescu G.I., et al. Recombinant human bone morphogenetic protein-2: a randomized trial in open tibial fractures treated with reamed nail fixation. J Bone Jt Surg Am 2011, 93:801-808.
18. Saiyed Z.M., Sharma S., Godawat R., Telang S.D., Ramchand C.N. Activity and stability of alkaline phosphatase (ALP) immobilized onto magnetic nanoparticles (Fe3O4). J Biotechnol 2007, 131:240-244.
19. Lin H., Zhao Y., Sun W., Chen B., Zhang J., Zhao W., et al. The effect of crosslinking heparin to demineralized bone matrix on mechanical strength and specific binding to human bone morphogenetic protein-2. Biomaterials 2008, 29:1189-1197.
20. Lui P.P., Chan L.S., Cheuk Y.C., Lee Y.W., Chan K.M. Expression of bone morphogenetic protein-2 in the chondrogenic and ossifying sites of calcific tendinopathy and traumatic tendon injury rat models. J Orthop Surg Res 2009, 4:27.
21. Majewski M., Betz O., Ochsner P.E., Liu F., Porter R.M., Evans C.H. Ex vivo adenoviral transfer of bone morphogenetic protein 12 (BMP-12) cDNA improves Achilles tendon healing in a rat model. Gene Ther 2008, 15:1139-1146.
22. Zhao Y., Zhang J., Wang X., Chen B., Xiao Z., Shi C., et al. The osteogenic effect of bone morphogenetic protein-2 on the collagen scaffold conjugated with antibodies. J Control Release 2010, 141:30-37.
23. Yoon E., Dhar S., Chun D.E., Gharibjanian N.A., Evans G.R. In vivo osteogenic potential of human adipose-derived stem cells/poly lactide-co-glycolic acid constructs for bone regeneration in a rat critical-sized calvarial defect model. Tissue Eng 2007, 13:619-627.
24. Han M., Kim J.M., Choi S.H., Lee F.Y., Son J.S., Oh D. Bone regeneration of tibial segmental defect using isotropic-pore structures hydroxyapatite/alumina bi-layered scaffold: in vivo pilot study. J Long Term Eff Med Implants 2011, 21:159-167.
25. Burg K.J., Porter S., Kellam J.F. Biomaterial developments for bone tissue engineering. Biomaterials 2000, 21:2347-2359.
26. Mainil-Varlet P., Rahn B., Gogolewski S. Long-term in vivo degradation and bone reaction to various polylactides. 1. One-year results. Biomaterials 1997, 18:257-266.
27. Walton M., Cotton N.J. Long-term in vivo degradation of poly-L-lactide (PLLA) in bone. J Biomater Appl 2007, 21:395-411.
28. Hollinger J.O., Battistone G.C. Biodegradable bone repair materials. Synthetic polymers and ceramics. Clin Orthop Relat Res 1986, 290-305.
29. Petersen N., Gatenholm P. Bacterial cellulose-based materials and medical devices: current state and perspectives. Appl Microbiol Biotechnol 2011, 91:1277-1286.
30. Klemm D., Schumann D., Udhardt U., Marsch S. Bacterial synthesized cellulose-artificial blood vessels for microsurgery. Prog Polym Sci 2001, 26:1561-1603.
31. Zverlov V.V., Schwarz W.H. Bacterial cellulose hydrolysis in anaerobic environmental subsystems-Clostridium thermocellum and Clostridium stercorarium, thermophilic plant-fiber degraders. Ann N Y Acad Sci 2008, 1125:298-307.
32. Karsenty G. Bone formation and factors affecting this process. Matrix Biol 2000, 19:85-89.
33. Albrektsson T., Johansson C. Osteoinduction, osteoconduction and osseointegration. Eur Spine J 2001, 10(Suppl. 2):S96-101.
34. Prochaska V.J., Lindgren J.U. Treatment of chronic tibial osteomyelitis, segmental bone loss, and soft tissue defect by bone transplant. Nebr Med J 1994, 79:349-352.
35. Maurer R.C., Dillin L. Multistaged surgical management of posttraumatic segmental tibial bone loss. Clin Orthop Relat Res 1987, 162-170.
36. Bostrom M.P., Camacho N.P. Potential role of bone morphogenetic proteins in fracture healing. Clin Orthop Relat Res 1998, S274-S282.
37. Johnson E.E., Urist M.R. One-stage lengthening of femoral nonunion augmented with human bone morphogenetic protein. Clin Orthop Relat Res 1998, 105-116.
38. Croteau S., Rauch F., Silvestri A., Hamdy R.C. Bone morphogenetic proteins in orthopedics: from basic science to clinical practice. Orthopedics 1999, 22:96-97. 686-95; quiz.
39. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 1994, 127:1755-1766.
40. Jiao X., Billings P.C., O'Connell M.P., Kaplan F.S., Shore E.M., Glaser D.L. Heparan sulfate proteoglycans (HSPGs) modulate BMP2 osteogenic bioactivity in C2C12 cells. J Biol Chem 2007, 282:1080-1086.